Patented Technology · FDA 510(k) Submission: Q2 2026

Form 211 Filed · OTC Markets

The problem isn't the treatment. It's how healthcare is designed.

Hyperbaric oxygen therapy is FDA-cleared for 14 conditions. Most patients still can't access it consistently.

See How This Fits Your Practice Schedule an Introductory Call

Get a 15-minute overview of clinical integration and implementation timelines

500,000+ physician practices. Fewer than 1,400 hyperbaric facilities.

The access gap represents an infrastructure transformation opportunity.

RxAir360 vertical hyperbaric chamber prototype - latest design iteration

Prototype of the RxAir360 Vertical Monoplace Hyperbaric Chamber — currently in premarket testing and pending FDA 510(k) clearance.

Who Are You?

Select your path below to see how RxAir360 is closing the access gap in hyperbaric medicine.

Two healthcare workers stand in a medical room next to a large blue hyperbaric oxygen chamber.

For Physicians

Decentralize Healing.
Maximize Your Practice.

Fits your 10×12 exam room—no remodeling
Up to $768,000 annual revenue
FDA 510(k) in process • ASME PVHO-1 compliant

Request a Physician Briefing

Receive an overview of clinical integration and implementation

For Investors

Build the Infrastructure
of Modern Medicine

$2.5B+ market opportunity
2 issued U.S. patents • 510(k) in process
Electroimpact engineering partnership

View Investor Portal

For Patients

Access Care Closer
to Home

14 FDA-cleared HBOT indications
95+ conditions researched
Treatment in your physician's office

Learn About HBOT

The Physician Access Gap

U.S. Physician Practices 500,000+

Hyperbaric Treatment Facilities Fewer than 1,400

When treatment exists but doesn't reach patients, the issue isn't clinical—it's structural.

A Pattern Repeating Across Healthcare

Dialysis

Once hospital-based

7,500+ outpatient centers

Imaging

Once hospital radiology

6,900+ freestanding facilities

Surgery

Once hospital ORs

6,300+ ambulatory surgery centers

Hyperbaric Medicine

Still largely hospital-based

Fewer than 1,400 facilities

When healthcare infrastructure moves closer to patients, access expands and markets grow. Hyperbaric medicine is entering that same transition.

A Founder's Perspective

"If hyperbaric oxygen therapy has been clinically recognized for decades, why does the United States still lack the infrastructure needed to make it broadly accessible?"

— Diallo M. Watts, Sr., Founder & CEO

Read the Full Founder's Letter

Built With Clinical and Engineering Leadership

Clinical Leadership

Dr. Jeffrey Niezgoda – former president APWCA/ACHM

Dr. Tyler Sexton – President, American College of Hyperbaric Medicine

Manufacturing

Electroimpact – precision engineering partner supporting Boeing and Airbus commercial aircraft programs

Intellectual Property

Two issued U.S. patents covering the vertical monoplace hyperbaric chamber design

Regulatory Pathway

FDA 510(k) submission targeted Q2 2026

Designed to ASME PVHO-1, IEC 60601-1, and NFPA 99 standards

Our Journey

Innovation in Progress

2023–2026

Engineering & Regulatory Development

Patent secured for vertical chamber design
Prototype development completed
Premarket testing underway

2026

510(k) Clearance Submission

FDA 510(k) submission in progress
Manufacturing scale-up preparation
Leasing infrastructure development